The global seasonal affective disorder therapeutics market is estimated to witness significant growth during the forecast period. Rising mental health awareness programs are primarily contributing to market growth. Governments of the countries have witnessed a major role to promote education about the mental conditions among people. As per the World Health Organization (WHO), 87% of all western pacific countries have a minimum of two active programs related to mental health prevention and promotion. Western Pacific countries include China, Australia, Singapore, Japan, New Zealand, and more.
A full report of Seasonal Affective Disorder Therapeutics Market is available at: https://www.omrglobal.com/industry-reports/seasonal-affective-disorder-therapeutics-market
As per the estimates by WHO, over 300 million people globally have depression, a rise of more than 18% during the period, 2005 and 2015. The 2017 “Let’s talk” campaign aims that more people suffering from depression globally, have access to treatment. It promotes workplace mental health and developing comprehensive prevention strategies for suicide. Further, as per the data published by the WHO in October 2019, nearly 54 million people in China have depression, and nearly 41 million have anxiety disorders.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/seasonal-affective-disorder-therapeutics-market
Healthy China 2019-2030 targets comprise 80% of patients with depression have treatment access by 2030 (and a minimum of 30% by 2022). This increasing focus on leverage access to treatment is expected to drive the demand for seasonal affective disorder treatment. The seasonal affective disorder is a form of depression which is associated with changes in seasons that start and ends at nearly the same times every year. Treatment for seasonal affective disorder comprise medications and light therapy (phototherapy). Light therapy is gaining significance for the treatment of the seasonal affective disorder. In light therapy, the patient sits or work near a light therapy box, which emits a bright light that imitates natural outdoor light.
Light therapy is expected to affect brain chemicals associated with mood and sleep, that provides ease from seasonal affective disorder symptoms. It may also support in sleep disorders, other kinds of depression, and other disorders. Light therapy is also referred to as phototherapy or bright light therapy. Innovations in light therapy have been reported, which is offering an opportunity for the growth of the market. For instance, in February 2019, Active Wearables, an Austrian Medtech startup launched Pocket Sky, a wearable which is designed to tackle conditions occurred due to poor access to sunlight and time shifts. It is worn as a pair of glasses and gives off blue light to mimic sunlight, apparently controlling melatonin production.
Light therapy can be difficult to achieve while travelling or at work. As a result, Pocket Sky enables patients to harness the benefits of light therapy with the use of a small wearable. Rising demand for wearables in healthcare is expected to accelerate the adoption of this wearable light therapy for the treatment of the seasonal affective disorder. This, in turn, will offer an opportunity for the global seasonal affective disorder therapeutics market.
Global Seasonal Affective Disorder Therapeutics Market- Segmentation
By Disorder Type
- Unipolar Disorder
- Bipolar Disorder
By Treatment Type
- Medications
- Light Therapy
- Others
